Guest: Deepa Rangachari, MD
With newly approved therapies on the rise, the way we treat non-small cell lung cancer patients with a RET gene rearrangement may be evolving. That’s why it’s so important to test for RET mutations in patients with non-small cell lung cancer, as oncologist Dr. Deepa Rangachari explains.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More